导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.10% | 2065/4773 |
| 近一周 | -0.48% | 1563/5467 |
| 近一月 | -4.86% | 1981/5421 |
| 近一季 | -11.95% | 3630/5238 |
| 近半年 | -5.39% | 3115/4931 |
| 近一年 | 6.16% | 1438/4400 |
| 近两年 | 74.42% | 927/2954 |
| 近三年 | 41.78% | 709/2253 |
| 成立以来 | 184.53% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.87% 844/4961 |
13.67% 1968/5312 |
- - |
- - |
| 2025 | 34.65% 1029/4813 |
3.41% 1092/3635 |
3.87% 931/4076 |
20.76% 1924/4524 |
3.82% 617/4813 |
| 2024 | 6.07% 1790/3463 |
-4.46% 1676/2808 |
-6.03% 1835/3014 |
15.10% 1812/3129 |
2.65% 913/3463 |
| 2023 | -0.15% 440/2656 |
10.33% 372/2280 |
-2.46% 596/2385 |
-5.35% 1309/2515 |
-1.97% 397/2655 |
| 2022 | -14.40% 369/2207 |
-11.21% 488/1919 |
6.30% 728/2016 |
-10.95% 475/2113 |
1.85% 1118/2208 |
| 2021 | 27.33% 91/1822 |
1.74% 242/1255 |
13.89% 275/1330 |
6.69% 213/1466 |
3.00% 486/1822 |
| 2020 | 40.18% 314/1250 |
4.18% 83/1028 |
20.33% 276/1067 |
8.85% 696/1164 |
2.74% 969/1184 |
| 2019 | 41.37% 233/1092 |
34.32% 117/754 |
-6.90% 531/804 |
3.42% 251/850 |
9.31% 235/918 |
| 2018 | - - |
- - |
- - |
- - |
-11.60% 323/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4796 | 32.41% |
| 港股通药 | 0.9109 | 32.37% |
| 港股通医疗ETF工银 | 0.9798 | 32.23% |
| 港股通医疗ETF华宝 | 0.9918 | 32.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8599 | 32.08% |
| 港股医疗 | 0.9703 | 31.90% |
| 港医疗 | 0.9212 | 31.83% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.9074 | 30.77% |
| 永赢中证港股通医疗主题ETF发起联接C | 0.9055 | 30.72% |
| 嘉实中证港股通创新药指数发起式A | 0.8665 | 30.57% |
| 富国中证1000指数增强(LOF)A VS. 长安沪深300非周期A(740101) |